• Français

Centre de recherche
Wednesday, March 13 2019

Dr. Jacques L. Michaud, member of the new CATALIS Québec Board of Directors

MONTREAL, March 13, 2019 – CATALIS’s management team is pleased to present the seven renowned directors, representing hospital management, the pharmaceutical industry and life science organizations, that became its board of directors on March 7th.

Dr. Marc Rivière, General Partner and Medical Director at TVM Life Science Management Inc., succeeds Ms. Diane Gosselin, President and CEO of CQDM, as chairperson of CATALIS Québec’s board of directors.

“I am pleased to help achieve CATALIS’s vision, which is to make Quebec a major centre for early-stage clinical research worldwide. I hope that CATALIS will serve as a vehicle to bridge the gap between the needs of industry, researchers and institutions to facilitate patient access to innovative therapies,” stated Dr. Marc Rivière.

“In 2017, the Government of Quebec tasked the CQDM with launching the CATALIS Initiative and the CATALIS Québec coordination office. All clinical research stakeholders in Quebec very quickly rallied around a common goal – that of finding solutions to maximize the performance of clinical trials conducted in Quebec and stimulating private investment in early-stage clinical research,” added Diane Gosselin, who remains the executive chair of CATALIS Québec.

CATALIS Québec is an independent, non-profit organization that receives financial support from the Ministère de l’Économie et de l’Innovation du Québec and the pharmaceutical industry.

The members of the board of directors are: Dr. Marc Rivière, TVM Life Science Management Inc.; Ms. Monique Lacroix, Novartis Pharmaceuticals Canada Inc.; Dr. Jacques L. Michaud, CHU Sainte-Justine Research Center; Ms. Carole Jabet, Centre hospitalier de l’Université de Montréal (CHUM); Ms. Louise Proulx, Corporate Director; Ms. Diane Gosselin, CQDM; Mr. Jefferson Tea, Takeda Canada Inc. For additional information, visit the “Governance” section of the CATALIS website.

About CATALIS

CATALIS Québec is a public-private partnership whose mission is to bring together stakeholders in Quebec’s life science sector in order to maximize private investment in early-stage clinical research and generate positive human, economic and social benefits. The member hospitals include the Centre hospitalier de l’Université de Montréal (CHUM), the McGill University Health Centre (MUHC), the Centre hospitalier universitaire Sainte-Justine, the Centre hospitalier universitaire (CHU) de Québec-Université Laval and the Centre hospitalier universitaire de Sherbrooke (CHUS). The private-sector partners of the CATALIS Initiative are: GlaxoSmithKline, Pfizer, Takeda, Abbvie, Merck, Servier, Novartis and Roche. catalisquebec.com

About the CHU Sainte-Justine Research Center

The CHU Sainte-Justine Research Center is a leading mother-child research institution affiliated with Université de Montréal. It brings together more than 200 research investigators, including over 90 clinician-scientists, as well as 500 graduate and postgraduate students focused on finding innovative prevention means, faster and less invasive treatments, as well as personalized approaches to medicine. The Center is part of CHU Sainte-Justine, which is the largest mother-child center in Canada and one of the four most important pediatric centres in North America. More on research.chusj.org

Persons mentioned in the text
About this page
Updated on 3/13/2019
Created on 3/13/2019
Alert or send a suggestion
 

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine